Back to search

Article

Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell Lymphoma

2024-11-20

Abstract excerpt

<title>Abstract</title> <p>Clinical tools to guide treatment decisions in relapsed and refractory mantle cell lymphoma (R/R MCL) are limited, and the translational potential of circulating tumor DNA (ctDNA) has remained largely undemonstrated. We designed and applied panel-based duplex sequencing to uncover molecular determinants of response and outcome in the ctDNA of R/R MCL patients treated with venetoclax, le...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec0630ee-6c82-5dcd-b727-9b328c9e3a05
DOI
10.21203/rs.3.rs-5331560/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell LymphomaDOI 10.21203/rs.3.rs-5331560/v1
Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphomaSemantic proximity
Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature ReviewSemantic proximity
Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity
Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution.Semantic proximity
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trialsSemantic proximity
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphomaSemantic proximity
Biological and clinical determinants shaping heterogeneity in mantle cell lymphomaSemantic proximity
Circulating Tumor DNA in Lymphoma.Semantic proximity
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.Semantic proximity
The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.Semantic proximity
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational researchSemantic proximity
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma.Semantic proximity
Select a neighboring publication to make it the new centre.